149 related articles for article (PubMed ID: 34088068)
1. Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis.
Alshehri AS; El-Kott AF; El-Kenawy AE; Khalifa HS; AlRamlawy AM
Sci Total Environ; 2021 Aug; 784():147182. PubMed ID: 34088068
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis.
BinMowyna MN; AlFaris NA; Al-Sanea EA; AlTamimi JZ; Aldayel TS
Arch Physiol Biochem; 2024 Jun; 130(3):300-315. PubMed ID: 35254877
[TBL] [Abstract][Full Text] [Related]
3. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
4. Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21.
Alshammari GM; Al-Qahtani WH; AlFaris NA; Alzahrani NS; Alkhateeb MA; Yahya MA
Biofactors; 2021 May; 47(3):489-505. PubMed ID: 33733575
[TBL] [Abstract][Full Text] [Related]
5. Oligochitosan-based nanovesicles for nonalcoholic fatty liver disease treatment via the FXR/miR-34a/SIRT1 regulatory loop.
Kong M; Peng Y; Qiu L
Acta Biomater; 2023 Jul; 164():435-446. PubMed ID: 37040811
[TBL] [Abstract][Full Text] [Related]
6. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.
Lee J; Padhye A; Sharma A; Song G; Miao J; Mo YY; Wang L; Kemper JK
J Biol Chem; 2010 Apr; 285(17):12604-11. PubMed ID: 20185821
[TBL] [Abstract][Full Text] [Related]
7. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis.
Simão AL; Afonso MB; Rodrigues PM; Gama-Carvalho M; Machado MV; Cortez-Pinto H; Rodrigues CMP; Castro RE
J Mol Med (Berl); 2019 Aug; 97(8):1113-1126. PubMed ID: 31139863
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
[TBL] [Abstract][Full Text] [Related]
10. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
[TBL] [Abstract][Full Text] [Related]
11. P53/miR-34a/SIRT1 positive feedback loop regulates the termination of liver regeneration.
Gong J; Cong M; Wu H; Wang M; Bai H; Wang J; Que K; Zheng K; Zhang W; Yang X; Gong J; Shi H; Miao M; Yuan F
Aging (Albany NY); 2023 Mar; 15(6):1859-1877. PubMed ID: 36988541
[TBL] [Abstract][Full Text] [Related]
12. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
Ding J; Li M; Wan X; Jin X; Chen S; Yu C; Li Y
Sci Rep; 2015 Sep; 5():13729. PubMed ID: 26330104
[TBL] [Abstract][Full Text] [Related]
13. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
Tian XF; Ji FJ; Zang HL; Cao H
PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
[TBL] [Abstract][Full Text] [Related]
14. trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways.
Karimi-Sales E; Jeddi S; Ebrahimi-Kalan A; Alipour MR
Food Funct; 2018 Aug; 9(8):4292-4298. PubMed ID: 30039136
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
[TBL] [Abstract][Full Text] [Related]
16. MiR-34a/Sirt1/p53 signaling pathway contributes to cadmium-induced nephrotoxicity: A preclinical study in mice.
Hao R; Song X; Sun-Waterhouse D; Tan X; Li F; Li D
Environ Pollut; 2021 Aug; 282():117029. PubMed ID: 33823310
[TBL] [Abstract][Full Text] [Related]
17. Pterostilbene Improves Hepatic Lipid Accumulation via the MiR-34a/Sirt1/SREBP-1 Pathway in Fructose-Fed Rats.
Wu WY; Ding XQ; Gu TT; Guo WJ; Jiao RQ; Song L; Sun Y; Pan Y; Kong LD
J Agric Food Chem; 2020 Feb; 68(5):1436-1446. PubMed ID: 31927917
[TBL] [Abstract][Full Text] [Related]
18. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
19. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.
Li X; Lian F; Liu C; Hu KQ; Wang XD
Sci Rep; 2015 Nov; 5():16774. PubMed ID: 26608583
[TBL] [Abstract][Full Text] [Related]
20. microRNA-34a aggravates coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway.
Jiang D; Li M; Yu Y; Shi H; Chen R
J Med Virol; 2019 Sep; 91(9):1643-1651. PubMed ID: 30968966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
